Hemant Surgical Industries Share Price
600.00-15.05 (-2.45%)
+73.61% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
POLYMED-ANSE
NURECA-TNSE
HSIL-MNSE
Hemant Surgical Industries Share Price
600.00-15.05 (-2.45%)
+73.61% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 0% |
| - | - | - | 0% |
| - | 22% | 46% | 78% |
| 13% | 13% | 13% | 13% |
Peer Comparison
Symbol
POLYMED-A
NURECA-T
HSIL-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,737.35 | ₹17504 Cr | 55.55 | 8.49 | 43.73 | ₹322 Cr |
| 344.95 | ₹324 Cr | 74.76 | 3.21 | 6.74 | ₹2 Cr |
| 600 | ₹894 Cr | 49.15 | 9.84 | 13.57 | ₹18 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 |
|---|
| — |
| ₹10 Cr |
| ₹53 Cr |
| ₹53 Cr |
| ₹63 Cr |
| ₹23 Cr |
| ₹66 L |
| -₹16 L |
| ₹55 L |
| ₹24 Cr |
| — |
| ₹39 Cr |
| ₹15 Cr |
| ₹3 Cr |
| ₹4 Cr |
| ₹61 Cr |
| ₹148 Cr |
| ₹6 Cr |
| ₹31 Cr |
| — |
| ₹47 Cr |
| ₹7 Cr |
| ₹40 Cr |
| ₹12 Cr |
| ₹1 Cr |
| ₹1 Cr |
| ₹6 Cr |
| ₹59 Cr |
| — |
| ₹43 Cr |
| ₹20 Cr |
| ₹10 Cr |
| ₹57 L |
| ₹15 Cr |
| ₹89 Cr |
| ₹28 Cr |
| ₹148 Cr |
| ₹61 |
| ₹61 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 |
|---|
| ₹10 Cr |
| ₹4 Cr |
| -₹4 Cr |
| ₹11 Cr |
| ₹9 Cr |
| -₹30 Cr |
| ₹18 Cr |
| -₹4 Cr |
| ₹13 Cr |
| ₹10 Cr |
Fundamental Ratios
Consolidated
Standalone
Hemant Surgical Industries Share Price
600.00-15.05 (-2.45%)
+73.61% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 4 out of 9 oscillators
RSI
75.45Buy
STOCH %K
93.36Sell
MACD Level(12,26)
49.51Buy
Ultimate Oscillator
77.05Buy
Aroon Oscillator
48.00Sell
BOP
0.13Buy
CCI
175.16Sell
Williams %R
-6.64Sell
Momentum
231.35Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
519.16Buy
SMA 9
495.64Buy
EMA 21
463.13Buy
SMA 21
440.91Buy
EMA 50
417.10Buy
SMA 50
400.11Buy
EMA 200
339.42Buy
SMA 200
334.79Buy
WMA 20
479.77Buy
Pivot
Pivot
Classic
Resistance 5
768.37
Resistance 4
726.82
Resistance 3
685.27
Resistance 2
643.72
Resistance 1
629.38
Pivot
602.17
Support 1
587.83
Support 2
560.62
Support 3
519.07
Support 4
477.52
Support 5
435.97
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Hemant Surgical Industries Share Price
600.00-15.05 (-2.45%)
+73.61% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|---|
| 58.90% | 58.90% | 58.90% | 73.56% | 73.56% | 73.56% |
| 0.15% | 0.15% | 0.15% | 0.39% | 0.00% | 0.00% |
| 10.73% | 10.81% | 10.81% | 1.11% | 1.13% | 1.97% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 30.22% | 30.14% | 30.14% | 24.94% | 25.31% | 24.47% |
Bulk & block deals
Name
Mona Laroia
Mona Laroia
Suresh Zunzunwala
Devendra Agarwal
Rohan Gupta
Suresh Zunzunwala
Suresh Zunzunwala
Gaurishankar Jhalani
Selvamurthy Akilandeswari
Multiplier Share & Stock Advisors Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 22 Aug 2025 | Purchase | 1.65 Cr | ₹279.45 | 59.20 K | Bulk | 0.454043 | BSE |
| 16 Jul 2025 | Purchase | 2.85 Cr | ₹189.70 | 1.50 L | Bulk | 1.153516 | BSE |
| 16 Jul 2025 | Purchase | 2.54 Cr | ₹182.64 | 1.39 L | Bulk | 1.067616 | BSE |
| 16 Jul 2025 | Sell | 1.43 Cr | ₹189.82 | 75.20 K | Bulk | 0.576758 | BSE |
| 16 Jul 2025 | Sell | 1.43 Cr | ₹189.82 | 75.20 K | Bulk | 0.576758 | BSE |
| 15 Jul 2025 | Purchase | 1.04 Cr | ₹172.57 | 60 K | Bulk | 0.460179 | BSE |
| 14 Jul 2025 | Purchase | 86.28 L | ₹156.31 | 55.20 K | Bulk | 0.423365 | BSE |
| 19 Jul 2024 | Purchase | 1.53 Cr | ₹203.83 | 75.20 K | Bulk | 0.576758 | BSE |
| 09 Jun 2023 | Purchase | 94.77 L | ₹160.09 | 59.20 K | Bulk | 0.454043 | BSE |
| 09 Jun 2023 | Sell | 1.60 Cr | ₹159.01 | 1.01 L | Bulk | 0.773101 | BSE |
Insider trading & SAST
Client name
Singularity Equity Fund I
Singularity Large Value Fund Iii
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02 Jun 2026 | Other | Acquisition | 4.98 | 6.9 | 0 | — | 6.50 L | 15 May 2026 | Allotment Of Warrants On Preferential Basis | 8,99,200 | SAST | 29(2) | — |
| 02 Jun 2026 | Other | Acquisition | 4.98 | 6.9 | 0 | — | 6.50 L | 15 May 2026 | Allotment Of Warrants On Preferential Basis | 8,99,200 | SAST | 29(2) | — |
Hemant Surgical Industries Share Price
600.00-15.05 (-2.45%)
+73.61% past 1 Year
Hemant surgical Industries Limited is engaged in the business of manufacturing, importing, assembly and marketing of medical equipments and disposables. Its product offerings cover a wide spectrum of equipment and
Corporate Actions
Date
Type
Details
Company details
Hemant Surgical Industries Share Price
600.00-15.05 (-2.45%)
+73.61% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Hemant Surgical Industries Share Price
600.00-15.05 (-2.45%)
+73.61% past 1 Year
News
Hemant surgical Industries zooms on inking pact with GBT Korea
Equity
HSIL
Hemant surgical Industries inks pact with GBT Korea
Equity
HSIL
Hemant surgical Industries touches roof on securing purchase order worth Rs 82.89 crore
Equity
HSIL
Hemant surgical Industries secures purchase order worth Rs 82.89 crore
Equity
HSIL
Hemant Surgical Industries informs about newspaper advertisement
Equity
HSIL
Hemant Surgical Industries acquires Solar Opto-Medic
Equity
HSIL
Hemant Surgical Industries informs about non-applicability of large corporate entity
Equity
HSIL
Hemant Surgical Industries informs about compliance certificate
Equity
HSIL
Hemant Surgical Industries informs about scrutinizer's report
Equity
HSIL
Hemant Surgical Industries informs about certificate
Equity
HSIL
Agi Greenpac: Co Names Sandip Somany As Md, Chairman
Equity
HSIL
Agi Greenpac: Q3 Ebitda 113.00 Crores Rupees Vs 81.10 Crores (Yoy) || Q3 Ebitda Margin 19.93% Vs 20.48% (Yoy)
Equity
HSIL
Agi Greenpac: Q3 Sl Net Profit 53.20 Crores Rupees Vs 29.40 Crores (Yoy); 33.90 Crores (Qoq) || Q3 Revenue 567.00 Crores Rupees Vs 396.00 Crores (Yoy); 512.00 Crores (Qoq)
Equity
HSIL
Agi Greenpac: Co Commences Commercial Production Of Speciality Glass Facility At Bhongir, Telangana
Equity
HSIL
Agi Greenpac: Q2 Ebitda 87.00 Crores Rupees Vs 71.00 Crores (Yoy) || Q2 Ebitda Margin 17% Vs 13% (Yoy)
Equity
HSIL
Agi Greenpac: Q2 Sl Net Profit 33.90 Crores Rupees Vs 31.10 Crores (Yoy); 65.80 Crores (Qoq) || Q2 Revenue 513.00 Crores Rupees Vs 309.00 Crores (Yoy); 523.00 Crores (Qoq)
Equity
HSIL